Human Sodium Balance Study (MEASURE)

November 26, 2024 updated by: Cheryl Anderson, University of California, San Diego

Sodium Regulation in Individuals on Known Dietary Sodium Intake

The overall objective of this study is to examine how dietary sodium is used by the body. In a racially diverse sample of adults, the investigators will examine the effects of high and low dietary sodium intake on the storage and excretion of sodium and determine whether sodium distribution affects blood pressure. This has implications for how investigators interpret studies that use urine biomarkers of sodium. Study findings about tissue sodium storage also have implications for managing hypertension and related conditions.

Study Overview

Study Type

Interventional

Enrollment (Actual)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • San Diego, California, United States, 92093
        • University of California, San Diego

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 69 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • At least 18 years old;
  • Diagnosed with high blood pressure or pre-hypertension (systolic blood pressure (SBP) > 120 mm Hg or diastolic blood pressure (DBP) > 80 mm Hg);
  • Taking no more than two medications for high blood pressure;
  • Currently has a primary care provider;
  • Willing to eat all meals provided by the study for two 14-day feeding periods;
  • Willing to complete study measurement procedures.

Exclusion Criteria:

  • Diabetes;
  • Smoker;
  • Serious food allergies;
  • Currently pregnant or planning to become pregnant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High-low dietary sodium
High sodium diet (3400 mg/day) feeding period followed by low sodium diet (2300 mg/day) feeding period
Fourteen day feeding period of high dietary sodium (3400 mg/day)
Fourteen day feeding period of low dietary sodium (2300 mg/day)
Experimental: Low-high dietary sodium
Low sodium diet (2300 mg/day) feeding period followed by high sodium diet (3400 mg/day) feeding period
Fourteen day feeding period of high dietary sodium (3400 mg/day)
Fourteen day feeding period of low dietary sodium (2300 mg/day)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Estimated sodium concentration in skin and muscle
Time Frame: 60 days
The concentration of sodium in skin and muscle will be measured, and the difference in concentrations resulting from high versus low sodium intakes will be calculated. Skin and muscle sodium stores will be non-invasively quantified using 23sodium-magnetic resonance imaging (23Na-MRI).
60 days
Estimated sodium concentration in bone
Time Frame: 60 days
The concentration of sodium in bone will be measured, and the difference in concentrations resulting from high versus low sodium intakes will be calculated. Sodium storage in bone will be measured non-invasively using in vivo neutron activation analysis (IVNAA) technology to quantify the concentration of Na in the hand.
60 days
Concentration of sodium, potassium, and hormone regulators in excreted urine
Time Frame: 60 days
Urinary concentration of sodium, potassium, and hormones (renin, angiotensin, aldosterone, free cortisol, free cortisone, glucocorticoid, and mineralocorticoid) will be measured and variation over time will be calculated.
60 days
Blood pressure
Time Frame: 60 days
Blood pressure under high versus low dietary sodium conditions will be measured.
60 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Racial differences in concentrations of sodium in skin, muscle and bone
Time Frame: 60 days
Blacks/African Americans mean sodium concentrations versus the average of the means of each of the other racial/ethnic groups will be examined.
60 days
Racial differences in concentration of urinary potassium excretion
Time Frame: 60 days
The concentration of potassium excreted in urine will be compared between Blacks/African Americans versus the pooled sample of other racial/ethnic groups.
60 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Cheryl A Anderson, PhD, University of California, San Diego

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 10, 2021

Primary Completion (Actual)

August 12, 2024

Study Completion (Actual)

August 12, 2024

Study Registration Dates

First Submitted

August 23, 2019

First Submitted That Met QC Criteria

September 27, 2019

First Posted (Actual)

October 1, 2019

Study Record Updates

Last Update Posted (Actual)

November 29, 2024

Last Update Submitted That Met QC Criteria

November 26, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HL140488

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on High dietary sodium intake

Subscribe